Mercury Laboratories Ltd

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	55.52	52.4	50.12	49.69	42.82
Other Income	1.04	0.42	0.35	0.78	1.12
Stock Adjustments	-1.75	1.12	-0.43	1.72	0.36
Total Income	54.81	53.94	50.04	52.19	44.3
EXPENDITURE :
Raw Materials	23.81	24.55	19.8	22.04	17.42
Excise Duty	0	0.54	2.1	2.18	1.63
Power and Fuel Cost	1.31	1.24	1.18	1.12	1.07
Other Manufacturing Expenses	2.55	1.79	1.12	0.72	1.19
Employee Cost	7.83	7.34	6.9	7	6.24
Selling and Administration Expenses	12.02	13.38	11.25	11.22	9.67
Miscellaneous Expenses	0.54	0.28	0.62	0.66	0.18
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	6.77	4.84	7.07	7.25	6.91
Interest and Financial Charges	1.09	0.91	0.89	1.13	1.12
Profit before Depreciation and Tax	5.68	3.93	6.18	6.12	5.79
Depreciation	1.63	1.47	1.29	1.18	1.18
Profit Before Tax	4.05	2.45	4.89	4.93	4.6
Tax	1.21	0.44	2.19	1.01	1.29
Profit After Tax	2.84	2.01	2.7	3.92	3.31
Adjustment below Net Profit	0	0	-0.08	0	0
P and L Balance brought forward	0.37	0.06	0.05	0.03	0.02
Appropriations	2.22	1.7	2.7	3.9	3.3
P and L Bal. carried down	0.99	0.37	-0.02	0.05	0.03
Equity Dividend	0.22	0.22	0	0.18	0.18
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0.04	0.03
Equity Dividend (%)	15	15	15	15	15
Earning Per Share (Rs.)	23.63	16.78	22.53	32.38	27.36
Book Value	241.38	219.56	203.94	182.06	151.18
Extraordinary Items	0	0.03	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

55.52

52.4

50.12

49.69

42.82

Other Income

1.04

0.42

0.35

0.78

1.12

Stock Adjustments

-1.75

1.12

-0.43

1.72

0.36

Total Income

54.81

53.94

50.04

52.19

44.3

EXPENDITURE :

Raw Materials

23.81

24.55

19.8

22.04

17.42

Excise Duty

0.54

2.1

2.18

1.63

Power and Fuel Cost

1.31

1.24

1.18

1.12

1.07

Other Manufacturing Expenses

2.55

1.79

1.12

0.72

1.19

Employee Cost

7.83

7.34

6.9

6.24

Selling and Administration Expenses

12.02

13.38

11.25

11.22

9.67

Miscellaneous Expenses

0.54

0.28

0.62

0.66

0.18

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

6.77

4.84

7.07

7.25

6.91

Interest and Financial Charges

1.09

0.91

0.89

1.13

1.12

Profit before Depreciation and Tax

5.68

3.93

6.18

6.12

5.79

Depreciation

1.63

1.47

1.29

1.18

Profit Before Tax

4.05

2.45

4.89

4.93

4.6

Tax

1.21

0.44

2.19

1.01

1.29

Profit After Tax

2.84

2.01

2.7

3.92

3.31

Adjustment below Net Profit

-0.08

P and L Balance brought forward

0.37

0.06

0.05

0.03

0.02

Appropriations

2.22

1.7

2.7

3.9

3.3

P and L Bal. carried down

0.99

0.37

-0.02

0.05

0.03

Equity Dividend

0.22

0.18

Preference Dividend

Corporate Dividend Tax

0.04

0.03

Equity Dividend (%)

Earning Per Share (Rs.)

23.63

16.78

22.53

32.38

27.36

Book Value

241.38

219.56

203.94

182.06

151.18

Extraordinary Items

0.03

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	1.2	1.2	1.2	1.2	1.2
Reserves and Surplus	27.77	25.15	23.27	20.65	16.94
Total Shareholders Funds	28.97	26.35	24.47	21.85	18.14
Secured Loans	5.61	6.81	4.52	4.55	6.95
Unsecured Loans	5.04	3.97	3.85	2.97	2.05
Total Debt	10.65	10.78	8.37	7.52	9
Total Liabilities	39.62	37.13	32.84	29.37	27.14
APPLICATION OF FUNDS :
Gross Block	35.44	30.21	26.44	25.34	25.06
Less: Accum. Depreciation	11.06	9.43	8.05	6.76	5.58
Net Block	24.38	20.78	18.39	18.58	19.48
Capital Work in Progress	0	0.24	0.4	0	0
Investments	0.01	0.01	0.01	0.01	0.01
Current Assets, Loans and Advances
Inventories	6.78	7.69	7.61	6.43	4.39
Sundry Debtors	19.29	14.72	17.53	13.41	12.17
Cash and Bank Balance	1.48	3.79	1.44	1.27	1.17
Loans and Advances	5.35	4.47	5.77	6.82	5.3
Less: Current Liab. and Prov.
Current Liabilities	16.74	13.99	15.38	12.34	11.95
Provisions	0.94	0.58	2.91	4.8	3.42
Net Current Assets	15.22	16.1	14.06	10.79	7.66
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	39.61	37.13	32.86	29.38	27.15
Contingent Liabilities	1.15	1.12	1.42	1.41	0.91

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

1.2

Reserves and Surplus

27.77

25.15

23.27

20.65

16.94

Total Shareholders Funds

28.97

26.35

24.47

21.85

18.14

Secured Loans

5.61

6.81

4.52

4.55

6.95

Unsecured Loans

5.04

3.97

3.85

2.97

2.05

Total Debt

10.65

10.78

8.37

7.52

Total Liabilities

39.62

37.13

32.84

29.37

27.14

APPLICATION OF FUNDS :

Gross Block

35.44

30.21

26.44

25.34

25.06

Less: Accum. Depreciation

11.06

9.43

8.05

6.76

5.58

Net Block

24.38

20.78

18.39

18.58

19.48

Capital Work in Progress

0.24

0.4

Investments

0.01

Current Assets, Loans and Advances

Inventories

6.78

7.69

7.61

6.43

4.39

Sundry Debtors

19.29

14.72

17.53

13.41

12.17

Cash and Bank Balance

1.48

3.79

1.44

1.27

1.17

Loans and Advances

5.35

4.47

5.77

6.82

5.3

Less: Current Liab. and Prov.

Current Liabilities

16.74

13.99

15.38

12.34

11.95

Provisions

0.94

0.58

2.91

4.8

3.42

Net Current Assets

15.22

16.1

14.06

10.79

7.66

Miscellaneous Expenses not w/o

Total Assets

39.61

37.13

32.86

29.38

27.15

Contingent Liabilities

1.15

1.12

1.42

1.41

0.91

Mercury Laboratories Ltd

Enjoy Lifetime Free Delivery Trade